Caracterización clínica y de laboratorio del mieloma múltiple en el Instituto de Hematología e Inmunología

Ramón Rodríguez, Luis G; Rivera-Keeling, Carlos; Arencibia-Núñez, Alberto; Avila-Cabrera, Onel M; Izquierdo-Cano, Lissete; Espinosa-Estrada, Edgardo; González-Pinedo, Leslie; Quintero-Sierra, Yamilé; Gutiérrez-Díaz, Adys; Hernández-Padrón, Carlos.
Rev. cuba. hematol. inmunol. hemoter ; 29(4): 382-397, oct.-dic. 2013.
Artículo en Español | LILACS | ID: lil-695875

Documentos relacionados

  1. Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.
  2. Exosomes in multiple myeloma: from bench to bedside.
  3. NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
  4. Mexican Concensus of Multiple Myeloma.
  5. Chromothripsis as a pathogenic driver of multiple myeloma.
  6. Revisiting the Case of Sarah Newbury's Death from Mollities Ossium.
  7. Screening in Multiple Myeloma and Its Precursors: Are We There Yet?
  8. Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation.
  9. Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
  10. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.